Neal McInerney Investor Relations

McInerney Investor Relations was a boutique investor relations and strategic communications firm that specialized exclusively in the biotechnology and life sciences sectors. Founded and led by Neal McInerney, the firm provided high-touch advisory services to emerging healthcare companies, helping them communicate complex scientific and clinical data to the investment community. The company was instrumental in the growth of numerous biotech firms during the 1990s and 2000s, assisting with IPOs, secondary offerings, and corporate positioning. Known for its deep industry expertise, the firm operated as a key link between innovative drug developers and institutional investors. Following the death of its founder in 2013, the firm's operations were discontinued.